194 related articles for article (PubMed ID: 24952383)
1. Moyamoya syndrome and neurofibromatosis type 1.
Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.
Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG
Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789
[TBL] [Abstract][Full Text] [Related]
3. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy.
Lee ML; Chang TM; Yang RC; Yang AD; Chen M
Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic artery ischemic syndrome associated with neurofibromatosis and moyamoya syndrome.
Witmer MT; Levy R; Yohay K; Kiss S
JAMA Ophthalmol; 2013 Apr; 131(4):538-9. PubMed ID: 23430230
[No Abstract] [Full Text] [Related]
5. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 association with moyamoya disease.
Koc F; Yerdelen D; Koc Z
Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature.
Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A
Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349
[TBL] [Abstract][Full Text] [Related]
10. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
[TBL] [Abstract][Full Text] [Related]
11. Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis.
Barrall JL; Summers CG
Surv Ophthalmol; 1996; 40(6):500-4. PubMed ID: 8724642
[TBL] [Abstract][Full Text] [Related]
12. Scoliosis Secondary to Neurofibromatosis Type I Combined With Moyamoya Syndrome: A Case Report.
Zhang H; Luo Y; Guo D; Yao Z; Liu H; Zhang X
JBJS Case Connect; 2022 Jul; 12(3):. PubMed ID: 36137072
[TBL] [Abstract][Full Text] [Related]
13. Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report.
Arita H; Narita Y; Ohno M; Miyakita Y; Okita Y; Ide T; Shibui S
Childs Nerv Syst; 2013 Feb; 29(2):341-5. PubMed ID: 23108917
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.
Santoro C; Giugliano T; Kraemer M; Torella A; Schwitalla JC; Cirillo M; Melis D; Berlit P; Nigro V; Perrotta S; Piluso G
PLoS One; 2018; 13(7):e0200446. PubMed ID: 30001348
[TBL] [Abstract][Full Text] [Related]
15. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
Serafini NB; Serafini CB; Vinhas AS; Godinho MB
An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous presentation of malignant peripheral nerve sheath tumor and moyamoya disease associated with neurofibromatosis type 1 in a child.
Yoo SY; Hwang SM; Lee MK; Jo DS; Hwang PH
Turk J Pediatr; 2015; 57(2):202-5. PubMed ID: 26690608
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
Rosser TL; Vezina G; Packer RJ
Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
[TBL] [Abstract][Full Text] [Related]
19. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
